Insider Trading: Coliseum Capital Buys More $LHCG

Christopher Shackelton and Adam Gray’s Coliseum Capital filed Form 4 for its insider purchases in LHC Group, Inc. (LHCG). According to the filings, Coliseum Capital bought totally 103 thousand shares in LHCG on November 4th, 7th and 8th, at the price near $14 per share. Coliseum Capital now takes 1.98 million shares in LHCG after the transaction, corresponding to a 10.6% passive stake ownership. In the third quarter Coliseum Capital has boosted its position by 239%, since it reported 829 thousand LHCG shares in its previous 13F filing. Now LHCG is trading at $13.89, and has already dropped by 54% in 2011.

LHC Group, Inc. (NASDAQ:LHCG)

Six other hedge funds were also bullish about LHCG in the second quarter. Chuck Royce’s Royce & Associates took the largest stake among the hedge funds, with 1.92 million shares at that time. Jim Simons’ Renaissance Technologies reported 77 thousand shares, up by 164% from Q1.

Coliseum Capital Management is a privately owned hedge fund. The firm invests in public equity markets. The firm is based in New York City, New York. The firm has a portfolio of $107 million, mainly invested in Services, Financial, and Healthcare sector.

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals in the United States. The company operates two segments: home-based services and facility-based services. The company was founded in 1994 and is based in Lafayette, Louisiana.